Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Discovery for Parkinson's With Mutations in the GBA Gene

NCT05536388 is registered in ClinicalTrials.gov with New York Stem Cell Foundation Research Institute as lead sponsor.

NCT NCT05536388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05536388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Discovery for Parkinson's With Mutations in the GBA Gene
Lead sponsor
New York Stem Cell Foundation Research Institute
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2022
Completion date
July 15, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease, gba gene mutation, healthy, parkinson disease